Prostate cancer

Showing 7 of 0 results

• Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study

  Annals of Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Metastatic breast cancer
  • Colorectal cancer
  • Non-small cell lung cancer
  • Prostate cancer
• Plasma circulating tumor DNA (ctDNA) fraction and real-world overall survival (rwOS) in metastatic castration resistant prostate cancer (mCRPC)

  ASCO Annual Meeting

  • Publications
  • Drug discovery
  • Prostate cancer
• Association of BRCA alteration type with real-world outcomes to PARP inhibitors in patients with metastatic castrate-resistant prostate cancer

  ASCO Annual Meeting

  • Publications
  • Drug discovery
  • Prostate cancer
• Prognostic significance of cancer patient reported outcomes in cancer

  Journal of Oncology Practice

  • Publications
  • Drug discovery
  • Prostate cancer
• An observational study of concomitant use of emerging therapies and denosumab or zoledronic acid in prostate cancer

  Clinical Therapeutics

  • Publications
  • Comparative effectiveness
  • Prostate cancer
• Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States

  Pharmacoepidemiology & Drug Safety

  • Publications
  • Treatment patterns
  • Prostate cancer
• Initiation and adherence with bone-targeting agents in US men with bone metastases from prostate cancer

  ASCO Annual Meeting

  • Publications
  • Treatment patterns
  • Prostate cancer